Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

URGENT CARE AT LAKE LUCILLE INC

NPI: 1275587768 · WASILLA, AK 99654 · Urgent Care Clinic/Center · NPI assigned 05/20/2006

$1.44M
Total Medicaid Paid
15,437
Total Claims
13,155
Beneficiaries
25
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialVAROSI, ELLEN (FINANCIAL OFFICER)
NPI Enumeration Date05/20/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,311 $282K
2019 2,699 $296K
2020 1,584 $167K
2021 3,162 $207K
2022 2,234 $188K
2023 1,414 $115K
2024 2,033 $181K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 5,005 4,310 $643K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2,716 2,503 $346K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,048 2,583 $289K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 477 422 $23K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 263 247 $23K
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 691 620 $20K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 32 31 $16K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 86 77 $15K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 475 446 $13K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 440 361 $13K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 744 320 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 163 145 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 472 405 $6K
0002A 185 136 $5K
0001A 153 127 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 44 31 $1K
81025 26 24 $223.86
36415 Collection of venous blood by venipuncture 75 70 $39.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 39 26 $21.95
81003 44 43 $3.08
99072 102 97 $0.00
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 82 74 $0.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 20 15 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 15 15 $0.00
J7050 Infusion, normal saline solution, 250 cc 40 27 $0.00